Harvey Finkelstein, MD: Intravenous Acetaminophen Now Available

In November 2010 the Food and Drug Administration approved for use in the United States an intravenous formulation of acetaminophen, which is the active ingredient in the OTC pain medication Tylenol. The new drug, known as Ofirmev, has been available from Cadence Pharmaceuticals, a San Diego-based drug company, as of this past Tuesday, January 18.

Ofirmev will be used by pain specialists such as Dr. Harvey Finkelstein, MD, in hospitals to control pain and fever. Ofirmev will be used in place of more dangerous analgesics such as opium-based morphine, as well as an adjunct to traditional treatments which can therefore be given in smaller doses, reducing their risk.

Comments are closed.